NCT04369248View on ClinicalTrials.gov

Hepassocin Levels in Patients With Polycystic Ovary Syndrome

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

March 15, 2020

Study Completion Date

March 25, 2020

Conditions
Hepassocin (Hepatocyte-derived Fibrinogen-related Protein 1)Polycystic Ovary SyndromeObesityInsulin Resistance
Interventions
OTHER

hepassocin

hepassocin levels in polycystic ovary syndrome

Trial Locations (1)

Unknown

Gaziosmanpasa Taksim Education and Research Hospital, Istanbul

All Listed Sponsors
lead

Fatma ketenci gencer

OTHER_GOV

NCT04369248 - Hepassocin Levels in Patients With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter